Sustainability Investors Products Research & Development Company Contact
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management
Type and search

All notices

Hofseth BioCare - Board member received proxies to vote for 8.6% of the shares at EGM

22.03.2013

Hofseth BioCare - CFO received proxies to vote for 41% of the shares at EGM

22.03.2013

Hofseth BioCare - Delivers more protein to the United States

21.03.2013

Hofseth BioCare - Notice of EGM

01.03.2013

Hofseth BioCare - Disclosure of large shareholdings

01.03.2013

Hofseth BioCare - Issues 400,000 shares according to option-program

01.03.2013

Hofseth BioCare - Allocation to primary insiders in private placement

01.03.2013

Hofseth BioCare - Completed private placement

01.03.2013

Hofseth BioCcare - Contemplated private placement

28.02.2013

Hofseth Biocare - Fourth quarter 2012 results

28.02.2013

Previous
22 23 24
25
26 27 28
...
30
Next
Sustainability
ESG Environment Social
Investors
Reasons to invest Share information News Reports Corporate governance Stock exchange notices
Products
Salmon protein hydrolysate Salmon oil Calcium bone powder Collagen peptides European webshops
Research & Development
Our research All research programs Studies Clinical Trial Unit
Company
About us Our technology Operations Management Board of directors Awards
Contact
Sales Investor relations Factories Management

Copyright 2021 Hofseth BioCare ASA
Privacy cookies